{
    "Trade/Device Name(s)": [
        "INRatio\u00ae 2 PT Monitoring System"
    ],
    "Submitter Information": "HemoSense, Inc.",
    "510(k) Number": "K072727",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020679"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJS"
    ],
    "Summary Letter Date": "October 26, 2007",
    "Summary Letter Received Date": "September 26, 2007",
    "Submission Date": "September 24, 2007",
    "Regulation Number(s)": [
        "21 CFR 864.7750"
    ],
    "Regulation Name(s)": [
        "Prothrombin Time Test"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin Time (PT)"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "INRatio\u00ae 2 PT Monitoring System"
    ],
    "Method(s)/Technology(ies)": [
        "Modified one-stage Prothrombin Time test",
        "Electrical impedance detection",
        "Recombinant human thromboplastin reagent"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Monitoring System"
    ],
    "Document Summary": "FDA 510(k) summary for INRatio 2 PT Monitoring System for quantitative measurement of prothrombin time in whole blood",
    "Indications for Use Summary": "Used for quantitative measurement of Prothrombin Time (PT) in fresh capillary whole blood for people taking warfarin and other oral anticoagulant therapy; not intended for screening purposes.",
    "fda_folder": "Hematology"
}